Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Trials Management

Neither a doctor nor a teaching hospital

Research payments

$113,469

47 payments

Through program year 2025, Clinical Trials Management is reported as receiving $113,469 in research payments, across 47 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $40,011 3
2024 Research $13,417 1
2023 Research $11,232 13
2022 Research $36,469 17
2021 Research $12,340 13

Breakdown

Who paid Research payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $52,866 6 payments
  2. Exeltis, USA Inc. $34,103 36 payments
  3. E.R. Squibb & Sons, L.L.C. $26,272 2 payments
  4. Mylan Inc. $167 2 payments
  5. Mylan Technologies Inc. $61 1 payment
Studies the money was for Research payments · program years 2021–2025
  1. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $52,866 6 payments
  2. A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants with Moderate-to-Severe Plaque Psoriasis (PragmaTYK) $26,272 2 payments
  3. A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles $12,340 13 payments
  4. Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability of LPRI-424, 13 Cycles $10,976 15 payments
  5. LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $10,788 8 payments
  6. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $167 2 payments
  7. Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $61 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record